Recorded adverse events and associated factors after CT-guided microwave ablation of pulmonary nodules: a retrospective cohort study
Background Adverse events after computed tomography (CT)-guided microwave ablation(MWA) of pulmonary nodules include imaging findings, symptoms, and events requiring treatment. We described the recorded event spectrum and explored associated patient and lesion characteristics. Methods This retrospective single-centre study analysed 189 patient-level records from a two-department retrospective cohort treated at Zhongshan Hospital of Xiamen University between January 1, 2024, and May 31, 2026. The primary outcome was a broad composite of recorded post-ablation adverse events, including imaging findings and minor symptoms irrespective of treatment requirement. Severity was reported separately using the conventional Society of Interventional Radiology (SIR) classification. Exploratory logistic regression included sex, documented chronic obstructive pulmonary disease (COPD), maximum nodule diameter, and a three-degree-of-freedom natural cubic spline for target-to-pleura distance. Model specification was data-informed. Post hoc analyses also examined major complications and intervention-requiring pneumothorax. Results Any recorded adverse event occurred in 97 of 189 patients (51.3%). Pneumothorax occurred in 84 patients (44.4%) and was present in 86.6% of those with any event. Among event-positive patients, 70 (72.2%) had a highest SIR class of A or B. Major complications, defined as a highest conventional SIR class of C–F, occurred in 27 patients (14.3%); all were class C or D. Pneumothorax required aspiration or chest-tube drainage in 46 patients (24.3%), including chest-tube drainage in 24 (12.7%). In post hoc analyses, diameter association estimates were attenuated relative to the broad-composite analysis: the adjusted odds ratio per 1-cm increase was 1.39 (95% confidence interval 0.77–2.49) for major complications and 1.72 (1.03–2.87) for intervention-requiring pneumothorax. Conclusions Pneumothorax was the predominant recorded adverse event after pulmonary MWA, but the broad composite rate should not be equated with the major-complication rate. Diameter association estimates were attenuated for clinically meaningful endpoints, limiting clinical extrapolation of the primary model. Safety assessment should emphasise event-specific severity and management alongside overall event frequency.
Authors
- 杜艳萍
- Yue Wu (ORCID: https://orcid.org/0000-0002-2505-7842)
- Pingyang Hong
- Shixin Hong
- Anke Hu
- Hanhan Chen
- Yanlin Huang
Institutions
- Fujian Medical University (CN)
- Xiamen University (CN)
- Zhongshan Hospital of Xiamen University (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2026-11-17
- DOI
- https://doi.org/10.3389/fmed.2026.2012686
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00